Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |